Concepts (202)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Education, Pharmacy | 10 | 2023 | 102 | 3.110 |
Why?
|
| Pharmacists | 8 | 2020 | 125 | 2.700 |
Why?
|
| Students, Pharmacy | 9 | 2021 | 79 | 2.190 |
Why?
|
| Societies, Pharmaceutical | 3 | 2020 | 22 | 1.590 |
Why?
|
| Pharmaceutical Services | 6 | 2023 | 47 | 1.510 |
Why?
|
| Community Pharmacy Services | 2 | 2020 | 11 | 1.480 |
Why?
|
| Pharmacy | 2 | 2023 | 26 | 1.020 |
Why?
|
| Osteoporosis | 4 | 2011 | 88 | 0.990 |
Why?
|
| Patient Education as Topic | 6 | 2011 | 425 | 0.920 |
Why?
|
| Interprofessional Relations | 3 | 2021 | 188 | 0.810 |
Why?
|
| Education, Pharmacy, Graduate | 3 | 2014 | 18 | 0.810 |
Why?
|
| Pharmacy and Therapeutics Committee | 1 | 2020 | 7 | 0.740 |
Why?
|
| Advisory Committees | 2 | 2020 | 73 | 0.740 |
Why?
|
| Medical Record Linkage | 1 | 2020 | 42 | 0.720 |
Why?
|
| Health Services Needs and Demand | 1 | 2020 | 149 | 0.680 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2020 | 130 | 0.680 |
Why?
|
| Patient Compliance | 4 | 2009 | 402 | 0.660 |
Why?
|
| Advanced Cardiac Life Support | 1 | 2016 | 22 | 0.560 |
Why?
|
| Cooperative Behavior | 4 | 2021 | 235 | 0.550 |
Why?
|
| Patient Simulation | 1 | 2016 | 64 | 0.540 |
Why?
|
| Patients | 1 | 2016 | 69 | 0.540 |
Why?
|
| Medical Errors | 1 | 2016 | 80 | 0.530 |
Why?
|
| Schools, Pharmacy | 5 | 2021 | 36 | 0.500 |
Why?
|
| Guideline Adherence | 2 | 2009 | 287 | 0.490 |
Why?
|
| Communication | 2 | 2018 | 329 | 0.490 |
Why?
|
| Practice Guidelines as Topic | 3 | 2009 | 772 | 0.480 |
Why?
|
| Bone Density Conservation Agents | 3 | 2011 | 43 | 0.480 |
Why?
|
| Patient Care Team | 1 | 2016 | 311 | 0.470 |
Why?
|
| Family Practice | 2 | 2009 | 312 | 0.460 |
Why?
|
| Specialization | 1 | 2014 | 66 | 0.460 |
Why?
|
| Clinical Competence | 4 | 2023 | 657 | 0.440 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2014 | 77 | 0.440 |
Why?
|
| Humans | 37 | 2023 | 68618 | 0.440 |
Why?
|
| Health Personnel | 2 | 2021 | 286 | 0.420 |
Why?
|
| Telemedicine | 1 | 2020 | 700 | 0.410 |
Why?
|
| Absorptiometry, Photon | 2 | 2009 | 83 | 0.410 |
Why?
|
| Ambulatory Care | 4 | 2009 | 340 | 0.400 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 3 | 2007 | 148 | 0.370 |
Why?
|
| Attitude of Health Personnel | 3 | 2020 | 442 | 0.360 |
Why?
|
| United States | 8 | 2021 | 7367 | 0.350 |
Why?
|
| Education, Graduate | 2 | 2008 | 30 | 0.340 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2009 | 20 | 0.330 |
Why?
|
| Ambulatory Care Facilities | 1 | 2009 | 91 | 0.330 |
Why?
|
| Evidence-Based Medicine | 2 | 2011 | 438 | 0.330 |
Why?
|
| Interdisciplinary Communication | 1 | 2009 | 93 | 0.320 |
Why?
|
| Cholesterol, LDL | 2 | 2005 | 161 | 0.310 |
Why?
|
| Curriculum | 7 | 2023 | 575 | 0.310 |
Why?
|
| Schools, Medical | 1 | 2009 | 157 | 0.300 |
Why?
|
| Camphor | 1 | 2007 | 1 | 0.290 |
Why?
|
| Patient Care | 1 | 2007 | 61 | 0.290 |
Why?
|
| Hormone Replacement Therapy | 1 | 2006 | 20 | 0.280 |
Why?
|
| Complementary Therapies | 1 | 2006 | 43 | 0.270 |
Why?
|
| Professional Role | 4 | 2009 | 80 | 0.270 |
Why?
|
| Diabetes Mellitus | 3 | 2009 | 694 | 0.270 |
Why?
|
| Postmenopause | 1 | 2006 | 93 | 0.270 |
Why?
|
| Pharmacy Service, Hospital | 2 | 2012 | 52 | 0.270 |
Why?
|
| Electronic Health Records | 1 | 2009 | 374 | 0.260 |
Why?
|
| Educational Measurement | 3 | 2016 | 254 | 0.260 |
Why?
|
| Women's Health | 1 | 2006 | 148 | 0.260 |
Why?
|
| Ciprofloxacin | 1 | 2005 | 30 | 0.260 |
Why?
|
| Intensive Care Units | 1 | 2007 | 344 | 0.250 |
Why?
|
| Parathyroid Hormone | 1 | 2005 | 117 | 0.240 |
Why?
|
| Thrombocytopenia | 1 | 2005 | 122 | 0.240 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2009 | 504 | 0.240 |
Why?
|
| Female | 16 | 2016 | 38074 | 0.230 |
Why?
|
| Academic Medical Centers | 1 | 2005 | 281 | 0.230 |
Why?
|
| Anti-Infective Agents | 1 | 2005 | 166 | 0.220 |
Why?
|
| South Carolina | 7 | 2012 | 2752 | 0.220 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2003 | 22 | 0.220 |
Why?
|
| Competency-Based Education | 1 | 2023 | 32 | 0.210 |
Why?
|
| Pirenzepine | 1 | 2001 | 17 | 0.200 |
Why?
|
| Diabetic Ketoacidosis | 1 | 2001 | 20 | 0.200 |
Why?
|
| Health Occupations | 1 | 2021 | 28 | 0.190 |
Why?
|
| Internship, Nonmedical | 2 | 2012 | 19 | 0.190 |
Why?
|
| Smoking Cessation | 1 | 2009 | 1034 | 0.180 |
Why?
|
| Attitude to Computers | 1 | 2020 | 38 | 0.180 |
Why?
|
| Antipsychotic Agents | 1 | 2001 | 247 | 0.170 |
Why?
|
| Forecasting | 1 | 2020 | 277 | 0.170 |
Why?
|
| Male | 10 | 2016 | 37321 | 0.170 |
Why?
|
| Young Adult | 3 | 2016 | 5717 | 0.160 |
Why?
|
| Students, Nursing | 2 | 2018 | 101 | 0.160 |
Why?
|
| Education, Distance | 1 | 2018 | 34 | 0.160 |
Why?
|
| Quality of Life | 1 | 2006 | 1515 | 0.150 |
Why?
|
| Problem-Based Learning | 1 | 2018 | 72 | 0.150 |
Why?
|
| Quality of Health Care | 2 | 2014 | 322 | 0.150 |
Why?
|
| Pandemics | 1 | 2021 | 352 | 0.150 |
Why?
|
| User-Computer Interface | 1 | 2018 | 230 | 0.140 |
Why?
|
| Knowledge | 1 | 2016 | 18 | 0.140 |
Why?
|
| Manikins | 1 | 2016 | 42 | 0.140 |
Why?
|
| Feedback | 1 | 2016 | 90 | 0.140 |
Why?
|
| Students, Health Occupations | 1 | 2016 | 33 | 0.140 |
Why?
|
| Education | 1 | 2016 | 83 | 0.130 |
Why?
|
| Physician Assistants | 1 | 2016 | 47 | 0.130 |
Why?
|
| Aged | 6 | 2009 | 14862 | 0.130 |
Why?
|
| Data Collection | 4 | 2010 | 420 | 0.120 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 767 | 0.120 |
Why?
|
| Pharmacy Residencies | 1 | 2014 | 18 | 0.120 |
Why?
|
| Middle Aged | 7 | 2009 | 21147 | 0.110 |
Why?
|
| Caregivers | 1 | 2016 | 365 | 0.110 |
Why?
|
| Computer Simulation | 1 | 2016 | 706 | 0.110 |
Why?
|
| Time Factors | 1 | 2020 | 4655 | 0.100 |
Why?
|
| Norpregnadienes | 1 | 2011 | 3 | 0.100 |
Why?
|
| Contraceptives, Postcoital | 1 | 2011 | 3 | 0.100 |
Why?
|
| Levonorgestrel | 1 | 2011 | 6 | 0.100 |
Why?
|
| Professional Competence | 2 | 2009 | 100 | 0.100 |
Why?
|
| Retrospective Studies | 4 | 2009 | 7277 | 0.100 |
Why?
|
| Unsafe Sex | 1 | 2011 | 34 | 0.100 |
Why?
|
| Adult | 5 | 2016 | 21403 | 0.090 |
Why?
|
| Clinical Trials as Topic | 2 | 2005 | 848 | 0.090 |
Why?
|
| Peer Review | 1 | 2009 | 16 | 0.090 |
Why?
|
| Documentation | 1 | 2009 | 83 | 0.080 |
Why?
|
| Life Style | 1 | 2011 | 338 | 0.080 |
Why?
|
| Faculty | 1 | 2009 | 56 | 0.080 |
Why?
|
| Surveys and Questionnaires | 4 | 2020 | 2800 | 0.080 |
Why?
|
| Peer Group | 1 | 2009 | 104 | 0.080 |
Why?
|
| Personal Satisfaction | 2 | 2008 | 123 | 0.080 |
Why?
|
| Physicians, Family | 1 | 2009 | 83 | 0.080 |
Why?
|
| Drug Utilization | 1 | 2009 | 119 | 0.080 |
Why?
|
| Primary Health Care | 1 | 2014 | 703 | 0.080 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2008 | 29 | 0.080 |
Why?
|
| Marketing of Health Services | 1 | 2008 | 18 | 0.080 |
Why?
|
| Financial Management | 1 | 2008 | 10 | 0.080 |
Why?
|
| Fractures, Bone | 1 | 2009 | 132 | 0.080 |
Why?
|
| Teaching | 1 | 2009 | 169 | 0.080 |
Why?
|
| Ulcer | 1 | 2007 | 27 | 0.070 |
Why?
|
| Models, Organizational | 1 | 2008 | 97 | 0.070 |
Why?
|
| Thromboembolism | 1 | 2007 | 91 | 0.070 |
Why?
|
| Teriparatide | 1 | 2006 | 7 | 0.070 |
Why?
|
| Anticoagulants | 1 | 2009 | 356 | 0.070 |
Why?
|
| Sulfonylurea Compounds | 1 | 2006 | 17 | 0.070 |
Why?
|
| Models, Theoretical | 1 | 2009 | 384 | 0.070 |
Why?
|
| Eating | 1 | 2007 | 119 | 0.070 |
Why?
|
| Medication Errors | 1 | 2007 | 116 | 0.070 |
Why?
|
| Dietary Supplements | 1 | 2009 | 332 | 0.070 |
Why?
|
| Clofibric Acid | 1 | 2005 | 12 | 0.070 |
Why?
|
| Internet | 2 | 2012 | 390 | 0.070 |
Why?
|
| Niacin | 1 | 2005 | 12 | 0.070 |
Why?
|
| Metformin | 1 | 2006 | 63 | 0.070 |
Why?
|
| Stress, Physiological | 1 | 2007 | 215 | 0.070 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2005 | 58 | 0.060 |
Why?
|
| Hypolipidemic Agents | 1 | 2005 | 82 | 0.060 |
Why?
|
| American Heart Association | 1 | 2005 | 142 | 0.060 |
Why?
|
| Child | 2 | 2007 | 6405 | 0.060 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2005 | 84 | 0.060 |
Why?
|
| Injections, Intravenous | 1 | 2005 | 215 | 0.060 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2005 | 178 | 0.060 |
Why?
|
| Qualitative Research | 1 | 2006 | 369 | 0.060 |
Why?
|
| Calcium | 1 | 2009 | 929 | 0.060 |
Why?
|
| Cerebrovascular Disorders | 1 | 2005 | 182 | 0.060 |
Why?
|
| Urinary Tract Infections | 1 | 2005 | 71 | 0.060 |
Why?
|
| Coronary Artery Bypass | 1 | 2005 | 218 | 0.060 |
Why?
|
| Health Surveys | 1 | 2006 | 489 | 0.060 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2007 | 189 | 0.060 |
Why?
|
| Vitamin D | 1 | 2009 | 516 | 0.060 |
Why?
|
| Minority Groups | 1 | 2006 | 197 | 0.060 |
Why?
|
| Inpatients | 1 | 2005 | 208 | 0.060 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2005 | 212 | 0.060 |
Why?
|
| Patient Satisfaction | 1 | 2006 | 378 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2007 | 1140 | 0.060 |
Why?
|
| Influenza Vaccines | 1 | 2004 | 56 | 0.060 |
Why?
|
| Hypoglycemic Agents | 1 | 2006 | 362 | 0.050 |
Why?
|
| Societies, Medical | 1 | 2005 | 403 | 0.050 |
Why?
|
| Cohort Studies | 1 | 2009 | 2358 | 0.050 |
Why?
|
| Nurses | 1 | 2003 | 53 | 0.050 |
Why?
|
| Vaccination | 1 | 2004 | 189 | 0.050 |
Why?
|
| Students, Medical | 1 | 2003 | 210 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2005 | 931 | 0.050 |
Why?
|
| Prospective Studies | 1 | 2009 | 3705 | 0.050 |
Why?
|
| Benzodiazepines | 1 | 2001 | 130 | 0.050 |
Why?
|
| Faculty, Pharmacy | 1 | 2020 | 13 | 0.040 |
Why?
|
| Myocardial Infarction | 1 | 2005 | 807 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2009 | 4848 | 0.040 |
Why?
|
| Coronary Artery Disease | 1 | 2005 | 696 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2005 | 1451 | 0.040 |
Why?
|
| Pancreatitis | 1 | 2001 | 279 | 0.040 |
Why?
|
| Career Choice | 2 | 2012 | 98 | 0.040 |
Why?
|
| Physicians | 1 | 2003 | 324 | 0.040 |
Why?
|
| Nursing Education Research | 1 | 2018 | 35 | 0.040 |
Why?
|
| Adolescent | 2 | 2009 | 8912 | 0.040 |
Why?
|
| Program Evaluation | 2 | 2012 | 502 | 0.040 |
Why?
|
| Simulation Training | 1 | 2018 | 49 | 0.040 |
Why?
|
| Internship and Residency | 1 | 2003 | 596 | 0.040 |
Why?
|
| Focus Groups | 1 | 2018 | 247 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2006 | 7029 | 0.040 |
Why?
|
| Feedback, Psychological | 1 | 2009 | 17 | 0.020 |
Why?
|
| Perception | 1 | 2009 | 189 | 0.020 |
Why?
|
| Program Development | 1 | 2009 | 240 | 0.020 |
Why?
|
| Raloxifene Hydrochloride | 1 | 2006 | 4 | 0.020 |
Why?
|
| Calcitonin | 1 | 2006 | 21 | 0.020 |
Why?
|
| Diphosphonates | 1 | 2006 | 39 | 0.020 |
Why?
|
| Needs Assessment | 1 | 2008 | 186 | 0.020 |
Why?
|
| Health Maintenance Organizations | 1 | 2006 | 22 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 2006 | 219 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2006 | 411 | 0.020 |
Why?
|
| Disease Management | 1 | 2006 | 248 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2006 | 649 | 0.010 |
Why?
|
| Decision Making | 1 | 2008 | 410 | 0.010 |
Why?
|
| Immunization Programs | 1 | 2004 | 25 | 0.010 |
Why?
|
| Influenza, Human | 1 | 2004 | 79 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2003 | 546 | 0.010 |
Why?
|
| Research Design | 1 | 2006 | 729 | 0.010 |
Why?
|
| Logistic Models | 1 | 2004 | 1420 | 0.010 |
Why?
|